LifeMD, Inc. (NASDAQ: LFMD) reported Q3 EPS of $0.08, $0.17 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.6 million versus the consensus estimate of $38.16 million.

GUIDANCE:

LifeMD, Inc. sees Q4 2023 revenue of $40-41 million, versus the consensus of $41.34 million.

LifeMD, Inc. sees FY2023 revenue of $148-149 million, versus the consensus of $148.6 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.